B. Storer

发表

Phase I clinical and pharmacokinetic trial of penclomedine using a novel, two-stage trial design for patients with advanced malignancy.

J. Berlin, G. Wilding, J. Stewart, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of 3-hour infusions of paclitaxel (Taxol) with or without granulocyte colony-stimulating factor.

J. Schiller, D. Spriggs, K. Tutsch, 1994, Seminars in oncology.

Characterization of the synergistic antiproliferative effects of interferon-gamma and tumor necrosis factor on human colon carcinoma cell lines.

J. Schiller, B. Storer, G. Bittner, 1990, Journal of interferon research.

Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines.

J. Willson, J. Schiller, B. Storer, 1987, Cancer research.

Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial.

M. Mehta, J. Schiller, T. Kinsella, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I study of 5-fluorouracil, leucovorin and levamisole

G. Wilding, P. Carbone, J. Cleary, 1997, Cancer Chemotherapy and Pharmacology.

Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).

B. Storer, D. Coldwell, N. Patel, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival.

J. Berlin, J. Schiller, W. Berry, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of a Combination of Interferon-βser and Interferon-γ in Patients with Advanced Malignant Melanoma

J. Willson, E. Borden, J. Schiller, 1988 .

Induced proteins in human peripheral mononuclear cells over a range of clinically tolerable doses of interferon-gamma.

E. Borden, G. Spear, B. Storer, 1989, Journal of interferon research.

A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies.

M. Mehta, J. Berlin, G. Wilding, 2004, Lung cancer.

Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretion.

J. Willson, J. Grem, D. Trump, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma.

J. Willson, E. Borden, J. Schiller, 1988, Journal of Interferon Research.

Photodynamic therapy of human malignant melanoma xenografts in athymic nude mice.

J. Sosman, J. Hank, B. Storer, 2018 .

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.

J. Schiller, D. Spriggs, K. Tutsch, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies

J. Schiller, D. Spriggs, K. Tutsch, 1993, Investigational New Drugs.

Antiproliferative effects of interferons -α and -β in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines

J. Schiller, J. Yingling, B. Storer, 1993 .

Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial.

E. Borden, R. Smalley, B. Storer, 1988, Journal of interferon research.

Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.

M. Mentzel, D. Katschinski, H. Robins, 1996, European journal of cancer.

Phase I trial of human lymphoblastoid interferon with whole body hyperthermia in advanced cancer.

E. Borden, H. Robins, B. Storer, 1989, Cancer research.

the influence of autologous lymphokine‐activated killer cell infusions on the toxicity and antitumor effect of repetitive cycles of interleukin‐2

R. Bechhofer, J. Sosman, B. Storer, 1990, Cancer.

Biological and Clinical Effects of the Combination of ÃŸ-and 7-Interferons Administered as a 5-Day Continuous Infusion1

E. Borden, J. Schiller, S. Grossberg, 2006 .

Comparison of spontaneous and induced mutation rates in an immortalized human bronchial epithelial cell line and its tumorigenic derivative.

J. Schiller, B. Storer, G. Bittner, 1997, Oncology.

Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell cancer of the lung.

J. Schiller, R. Dreicer, P. Carbone, 1989, Journal of the National Cancer Institute.